Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$37.07
+1.9%		$31.67
$17.86
▼
$38.10
$1.78B1.93654,915 shs1.25 million shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.72
+2.4%		$0.94
$0.70
▼
$1.65
$12.41M0.66109,419 shs27,463 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+1.90%-0.32%+18.51%+34.85%+47.98%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+2.42%-3.05%-11.76%-38.15%-46.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$37.07
+1.9%		$31.67
$17.86
▼
$38.10
$1.78B1.93654,915 shs1.25 million shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.72
+2.4%		$0.94
$0.70
▼
$1.65
$12.41M0.66109,419 shs27,463 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+1.90%-0.32%+18.51%+34.85%+47.98%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+2.42%-3.05%-11.76%-38.15%-46.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.18
Hold$31.38-15.36% Downside
IRIDEX Corporation stock logo
IRIX
IRIDEX
2.00
Hold$3.00314.59% Upside

Current Analyst Ratings Breakdown

Latest BLFS and IRIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/10/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/6/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/28/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/27/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Stephens logo
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$32.00 ➝ $31.00
7/27/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Stephens logo
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$32.00 ➝ $31.00
7/23/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$30.00 ➝ $31.00
7/23/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral$32.00 ➝ $31.00
7/23/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$31.00
7/22/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$33.00 ➝ $31.00
7/22/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$31.00
(Data available from 9/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M18.83$0.23 per share158.88$7.72 per share4.80
IRIDEX Corporation stock logo
IRIX
IRIDEX
$52.67M0.24N/AN/A($0.06) per share-12.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M$1.1631.96231.69N/A53.29%2.70%2.49%11/5/2026 (Estimated)
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$4.44M-$0.20N/AN/AN/A-6.88%N/A-12.55%11/17/2026 (Estimated)

Latest BLFS and IRIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026Q2 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.01-$0.07-$0.06-$0.07$13.59 million$12.57 million
8/6/2026Q2 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.0313$0.91+$0.8788$0.91$27.80 million$28.47 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
9.69
7.14
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/A
1.82
1.08

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
IRIDEX Corporation stock logo
IRIX
IRIDEX
8.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.86 million47.78 millionOptionable
IRIDEX Corporation stock logo
IRIX
IRIDEX
12017.57 million16.05 millionOptionable

Recent News About These Companies

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%
August 25, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2979959/iridex-q2-loss-widens-y-y-as-retina-weakness-weighs-stock-down-15?cid=cs-stocknewsapi-ft-microcap_article|earnings-2979959
Iridex: Q2 Earnings Snapshot
August 18, 2026  |  chron.comhttps://www.chron.com/business/article/iridex-q2-earnings-snapshot-22393604.php
Iridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocation
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4634593-iridex-reaffirms-2026-revenue-guidance-of-51m-53m-while-highlighting-working-capital-build
IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937971-iridex-corporation-irix-q2-2026-earnings-call-transcript
Iridex Reports Second Quarter 2026 Financial Results
August 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3347226/0/en/iridex-reports-second-quarter-2026-financial-results.html
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338802/0/en/iridex-to-report-second-quarter-2026-financial-results-on-august-18-2026.html
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3329611/0/en/iridex-adds-endoprobe-handpieces-to-eyeprogpo-product-offering.html
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
June 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/09/3309324/0/en/iridex-to-present-at-the-planet-microcap-las-vegas-2026-conference.html
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
May 25, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2926399/irix-stock-up-4-as-q1-loss-narrows-y-y-on-glaucoma-product-growth?cid=cs-stocknewsapi-ft-microcap_article|earnings-2926399
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
May 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/iridex-corp-irix-q1-2026-050019049.html
IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript
May 20, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/iridex-corporation-nasdaqirix-q1-2026-earnings-call-transcript-1765753/
Iridex reaffirms $51M-$53M 2026 revenue outlook while targeting $600,000 annualized cost reduction
May 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4595101-iridex-reaffirms-51m-53m-2026-revenue-outlook-while-targeting-600000-annualized-cost
Iridex (IRIX) Q1 2026 Earnings Transcript
May 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/iridex-irix-q1-2026-earnings-220320583.html
IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
May 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4906720-iridex-corporation-irix-q1-2026-earnings-call-transcript
Iridex Reports First Quarter 2026 Financial Results
May 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/19/3297948/0/en/iridex-reports-first-quarter-2026-financial-results.html
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
May 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/05/3288227/0/en/iridex-to-report-first-quarter-2026-financial-results-on-may-19-2026.html
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
April 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/07/3269622/0/en/iridex-announces-new-partnership-with-eyeprogpo-to-expand-member-access-to-retina-laser-technology.html
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth
April 1, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2893287/iridex-s-q4-loss-narrows-year-over-year-on-retina-sales-growth?cid=cs-stocknewsapi-ft-microcap_article|earnings-2893287
IRIDEX Corporation
March 31, 2026  |  cnn.comhttps://www.cnn.com/markets/stocks/IRIX
IRIDEX Corporation (NASDAQ:IRIX) Q4 2025 Earnings Call Transcript
March 27, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/iridex-corporation-nasdaqirix-q4-2025-earnings-call-transcript-1726207/

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$37.07 +0.69 (+1.90%)
As of 08/31/2026 04:00 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.72 +0.02 (+2.42%)
Closing price 08/31/2026 04:00 PM Eastern
Extended Trading
$0.72 -0.01 (-1.19%)
As of 05:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas